Sartorius Stedim Biotech and c-LEcta, a German biotechnology company, have signed a worldwide sales and distribution agreement for c-LEcta’s Serratia marcescens nuclease for biopharmaceutical applications. C-LEcta specializes in the development of customized enzymes and production strains for industrial applications. Under the agreement, customized endonuclease will now be available under the product name Denarase through all regular Sartorius Stedim Biotech sales channels. Endonucleases are us...